PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of ...

The Drugs Control department in Kerala checked 5,578 random samples from medical shops across the State in 2024, of which 132 were found to be of substandard quality (2.36%). Of the 164 sample ...

Medical Rubber Stoppers Market is Segmented by Type (Oral Liquid Stopper, Syringe Stopper, Freeze-dried Rubber Stopper), by Application (Regular Rubber Stopper, Film Covered Rubber Stopper, Coated ...

TAMPA, Fla., April 8, 2025 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA"), a Phase 3 immune-oncology company developing novel technologies to overcome resistance to cancer ...

For more and to view the abstract, visit the AACR Annual Meeting website. As previously announced, on December 11, 2024, TuHURA entered into a definitive agreement with Kineta, Inc. (OTC Pink ...

United Therapeutics (UTHR) announced that ten posters and presentations across its commercial ... Vice President, Global Medical Affairs at United Therapeutics. “We look forward to a ...

Her poster was recognised for its excellence amidst a highly competitive field of presentations. "I am incredibly pleased to have received this award," said Ify Nwiwu. "The symposium was very intense, ...

today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...

today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...

Two posters will highlight new data from the company’s open-label ASCENT study of LIQ861 (YUTREPIA) in PH-ILD patients with a focus on safety, tolerability, exploratory changes in 6-minute walk ...

KAT2A/B is a histone acetyltransferase that is associated with multiple tumor types. Details for Auron’s poster presentation are below and can be found via the AACR online itinerary planner: Abstract ...

Erasca will also present potential first-in-class examples of direct SMP complex inhibitors, representing a new approach to block the RAS/MAPK pathway SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE) -- ...